| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $41K | -60.2% |
| R&D Expense | $36.2M | -17.0% |
| SG&A Expense | $20.1M | +131.0% |
| Operating Income | -$56.2M | -7.7% |
| Net Income | -$56.2M | -8.5% |
| EPS (Basic) | -$1.42 | +55.2% |
| EPS (Diluted) | -$1.42 | +55.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.6M | +34.0% |
| Current Assets | $7.5M | +38.9% |
| Total Assets | $7.5M | +38.9% |
| Current Liabilities | $20.1M | +9.1% |
| Total Liabilities | $20.1M | +9.1% |
| Stockholders' Equity | -$12.6M | +3.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.1M | +34.6% |
| Financing Cash Flow | $32.8M | -19.0% |